Effect of the pretreatment with some cytostatic agents on the growth rate of leukaemia L5178Y.
D000179:Acrylates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D005998:Glycine / Q000008:administration & dosage / Q000627:therapeutic use; D007111:Immunity, Cellular / Q000187:drug effects; D007274:Injections, Intraperitoneal; D007942:Leukemia, Experimental / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use
D000179:Acrylates; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D004338:Drug Combinations; D009588:Nitrogen Mustard Compounds; D003520:Cyclophosphamide; D005998:Glycine